Botanix Closes Capital Raising and Royalty Milestone Buyout
Filed with ASX · · 3 pages · English
Botanix Pharmaceuticals Limited on 6ix
Story so far
Earlier from Botanix Pharmaceuticals
- Botanix Capital Raising to Extinguish Milestone & Royalty
- Botanix Pharmaceuticals: The West Australian | Botanix Pharmaceuticals secures $12.5m via an institutional placement
- New Territory Licensed for Sofpironium Bromide with Kaken
- March 2023 Quarterly Activities Report and Appendix 4C
- Botanix successfully completes A$10m Placement
Later from Botanix Pharmaceuticals
- June 2023 Quarterly Activities Report and Appendix 4C
- Appointment of Dr Howie McKibbon as CEO
- Appendix 4E Preliminary Final Report
- Response to ASX Price and Volume Query
- FDA Letter Requires Patient Instruction Update
Follow Botanix Pharmaceuticals into a list and get an email when it puts out news.
Follow Botanix Pharmaceuticals